2021
DOI: 10.1007/s00296-021-04867-7
|View full text |Cite
|
Sign up to set email alerts
|

Validation of the provisional seven-item criteria for the diagnosis of polyarteritis nodosa

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
2
0
2

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 16 publications
0
2
0
2
Order By: Relevance
“…Currently, the American College of Rheumatology (ACR) criteria published in 1990 are still in use to classify PAN 207 . However, new criteria are under investigation with the aim to increase sensitivity and specificity 208,209 . Over 60 disease‐associated mutations have been identified in all domains of ADA2, affecting its catalytic activity, protein dimerization, and secretion.…”
Section: Medium‐vessel Vasculitismentioning
confidence: 99%
See 1 more Smart Citation
“…Currently, the American College of Rheumatology (ACR) criteria published in 1990 are still in use to classify PAN 207 . However, new criteria are under investigation with the aim to increase sensitivity and specificity 208,209 . Over 60 disease‐associated mutations have been identified in all domains of ADA2, affecting its catalytic activity, protein dimerization, and secretion.…”
Section: Medium‐vessel Vasculitismentioning
confidence: 99%
“…207 However, new criteria are under investigation with the aim to increase sensitivity and specificity. 208,209 Over 60 disease-associated mutations have been identified in all domains of ADA2, affecting its catalytic activity, protein dimerization, and secretion. ADA2 is highly expressed in myeloid cells but its role in vasculitis pathogenesis has not yet been elucidated.…”
Section: Polyarteritis Nodosa: Neutrophils and Aneurysm As Potential ...mentioning
confidence: 99%
“…Estos criterios tienen una sensibilidad y especificidad para el diagnóstico del 82 y 87 por ciento respectivamente. Naidu et al, 2021) -Laboratorio: No existen pruebas de laboratorios específicas de diagnóstico de PAN, se realizan de rutina, hemograma, enzimas musculares, estudios de función hepática y renal, serologías de hepatitis B y C, uroanálisis De Virgilio et al, 2016, Iglesias et al, 1986. La elevación de la velocidad de sedimentación globular (VSG), y proteína C reactiva (PCR) son lo más frecuente, pero no aportan un valor significativo diagnóstico, ni descarta la enfermedad (Michelitti, 2022); es valioso reducir el diagnóstico diferencial por lo que se pueden hacer adicionales (Halabi et al, 2021) como: Anticuerpos anticitoplasma de neutrófilos (ANCA), anticuerpos antinucleares (ANA), anticuerpos anti-Ro, anticuerpos anti-La, anticuerpos anti ribonucleoproteína (Anti RNP), anticuerpos anti Smith, (Fett, 2022) componentes de complemento (C3 y C4), crioglobulinas, electroforesis en suero y orina, (Helfgott y Bhattacharyya, 2022;Schnappauf et al, 2021).…”
Section: Introductionunclassified
“…Una manera que se ha evidenciado para diferenciarla de otras vasculitis es mediante el resultado de ANCA séricos negativos. (Chercoles y Fong, 2016;Helfgott y Bhattacharyya, 2022;Zahoor et al, 2022;Gaviria et al, 2020, Naidu et al, 2021 -Imágenes: Angiorresonancia, Angiotomografía y/o Angiografía en las que se pueden observar dilataciones o estrechamientos de las arterias afectadas (Munera-Campos et al, 2020;Gabsi et al, 2021) como lo es la presencia de micro aneurismas, los cuales son distintivos de la PAN. (Wuelan, 2022) -Biopsia: se observa vasculitis leucocitoclástica de arterias de mediano calibre, necrosis de las paredes del vaso, asociado a marcada inflamación perilesional (Jennette, 2013;Sociedad Argentina de Reumatología, 2022), la biopsia debe centrarse sobre un nódulo sensible o una lesión purpúrica (Michelitti, 2022).…”
Section: Introductionunclassified